ACADIA PHARMA (NASDAQ:ACAD)
1.26
0.04 (3.08%)
| ACADIA PHARMA (NASDAQ:ACAD) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.30 | 52 Week High | $6.60 | ||
| Open | $1.26 | 52 Week Low | $0.75 | ||
| Day High | $1.30 | P/E | N/A | ||
| Day Low | $1.26 | EPS | $-1.34 | ||
| Volume | 109,389 | ||||
| More ACAD Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| BVF | 7 | MNKD | 3 |
| VRNMD | 2 | COT | 2 |
| WMT | 2 | CRMT | 2 |
| NTRI | 2 | ARP | 2 |
| ATCO | 2 | EDAP | 2 |
| PSTI | 2 | BEXP | 2 |
Entities who have mentioned ACAD
- 13G | View Related Stories »
- UBS | View Related Stories »
- Barclays | View Related Stories »
- Piper Jaffray | View Related Stories »
- Bakken Formation | View Related Stories »
- JPMorgan | View Related Stories »
- Goldman Sachs | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Morgan Stanley | View Related Stories »
- Sanford C. Bernstein | View Related Stories »
- Warburg Pincus | View Related Stories »
- Needham & Company | View Related Stories »
- Dividend | View Related Stories »
- Citi | View Related Stories »
- Deutsche Bank | View Related Stories »
- Jefferies & Co | View Related Stories »
- Layoffs | View Related Stories »
- Banc of America | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Soleil Securities | View Related Stories »
- Scopia Capital | View Related Stories »
- Jim Cramer | View Related Stories »
- Credit Suisse | View Related Stories »
- Stock Buyback | View Related Stories »
View All Major News StreetInsider.com Major News for ACAD
- Acadia Pharmaceuticals (ACAD) Tops Q3 EPS by 1c
- ACADIA (ACAD) Said Pimavanserin Fails To Meet Primary Endpoint In Parkinson's Trial
- Acadia Pharma (ACAD) Misses Q1 View By 4c
View All ReportsStreetInsider.com Reports on ACAD
- Acadia Pharmaceuticals (ACAD) Tops Q3 EPS by 1c
- ACADIA Pharma (ACAD) to Cut Workforce by 50%
- Unusual 11 Mid-Day Movers 10/06: FONR, ICTG, ACAD, AVCT Higher; MNKD, VRNMD, ARP, PPD Lower
- ACADIA Pharmaceuticals (ACAD) Shares Rise Sharply on Pimavanserin Update
- Morning Movers 10/06: FONR, ICTG, PEDH, AVCT, SRDX, NTRI Higher; VRNMD, MNKD, ARP, PSTI, EXTR, STJ Lower
View All Press ReleasesCompany Press Releases on ACAD
- ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 8, 2010
- Osteologix Announces Financing
StreetInsider Reports on ACAD by Category
View All BlogsBlogs on ACAD
- ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call
- 11 Ache-free Investment Opportunities in Neuropathic Pain
- Take Advantage of Biovail Weakness - RBC
- Biovail Makes Good on Promise to Transform into Niche Player in CNS Diseases
- Extreme FDA Trades: 30 Stocks Under 5 Bucks
View All FilingsSEC Filings on ACAD
- Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: DELAWARE MANAGEMENT HOLDINGS CO INC
- Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P
- Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: OXFORD BIOSCIENCE PARTNERS IV LP
- Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: OPPENHEIMER FUNDS INC
- Form 8-K ACADIA PHARMACEUTICALS For: Jan 22
Comments on ACAD
No comments are currently available.
